Obesity Pillars Roundtable: Obesity and East Asians

Overview

Journal Obes Pillars

Date 2023 Nov 22

PMID 37990717

Authors

Harold Edward Bays

Jennifer Ng

Jeffrey Sicat

Michelle Look

Affiliations

Soon will be listed here.

Abstract

Background: Individuals from East Asia make up about 1/5 of the world's population. Individuals from South Asia with obesity are well-described to have increased susceptibility to cardiovascular disease (CVD) risk factors and increased risk of CVD events. Less well described are the adiposopathic effects of the disease of obesity among East Asians.

Methods: This roundtable discussion includes 3 obesity medicine specialists with experience in the clinical management of obesity among patients of East Asian descent. Included are citations regarding obesity and East Asians.

Results: In general, East Asians are at decreased risk for CVD compared to Whites and South Asians. However, compared to Whites, for the same body mass index, East Asians are at increased risk for metabolic diseases such as type 2 diabetes mellitus. Both obesity and type 2 diabetes mellitus are epidemics in East Asian countries. In this Roundtable, the panelists discuss East Asian nutrition and physical activity, with special attention given to Asian foods, especially rice. The panelists also discuss East Asian genetic predispositions for development of visceral adiposity, type 2 diabetes mellitus, as well as genetic predisposition to drug metabolism and potential drug and herbal interactions, as commonly encountered in patients with obesity. Finally, the panelists give summary tips for managing East Asian patients with obesity.

Conclusion: The three panelists of this roundtable describe their practical diagnostic processes and treatment plans for patients from East Asia, with an emphasis on a patient-centered approach to obesity in this unique population.

Citing Articles

Changes in weight distribution and trends in obesity among children and adolescents in East Asia: Insights from NCD-RisC data.

Hong Y, Park S, Shin M, Chung S, Jung J, Sul A PLoS One. 2024; 19(11):e0310646.

PMID: 39531456 PMC: 11556726. DOI: 10.1371/journal.pone.0310646.

Estimated GFR in the Korean and US Asian Populations Using the 2021 Creatinine-Based GFR Estimating Equation Without Race.

Hwang J, Kim K, Coresh J, Inker L, Grams M, Shin J Kidney Med. 2024; 6(10):100890.

PMID: 39319209 PMC: 11420506. DOI: 10.1016/j.xkme.2024.100890.

Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.

Bays H, Kirkpatrick C, Maki K, Toth P, Morgan R, Tondt J Obes Pillars. 2024; 10:100108.

PMID: 38706496 PMC: 11066689. DOI: 10.1016/j.obpill.2024.100108.

Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023.

Bindlish S, Ng J, Ghusn W, Fitch A, Bays H Obes Pillars. 2023; 8:100092.

PMID: 38125656 PMC: 10728709. DOI: 10.1016/j.obpill.2023.100092.

Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023.

Clayton T, Fitch A, Bays H Obes Pillars. 2023; 8:100083.

PMID: 38125655 PMC: 10728712. DOI: 10.1016/j.obpill.2023.100083.

References

U S Department Of Health And Human Services . Opioid abuse in the United States and Department of Health and Human Services actions to address opioid-drug-related overdoses and deaths. J Pain Palliat Care Pharmacother. 2015; 29(2):133-9. DOI: 10.3109/15360288.2015.1037530. View

Liao J . Safety and efficacy of statins in Asians. Am J Cardiol. 2007; 99(3):410-4. PMC: 2651637. DOI: 10.1016/j.amjcard.2006.08.051. View

Gardiner P, Whelan J, White L, Filippelli A, Bharmal N, Kaptchuk T . A systematic review of the prevalence of herb usage among racial/ethnic minorities in the United States. J Immigr Minor Health. 2012; 15(4):817-28. PMC: 4401997. DOI: 10.1007/s10903-012-9661-z. View

Ji L, Chan J, Yu M, Yoon K, Kim S, Choi S . Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective. Diabetes Obes Metab. 2020; 23(1):3-17. PMC: 7756748. DOI: 10.1111/dom.14205. View

Kang Y, Cho Y, Lee J, Lee S, Lee W, Park J . Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials. Diabetes Metab J. 2019; 43(4):410-421. PMC: 6712219. DOI: 10.4093/dmj.2018.0070. View

Pare G, Caku A, McQueen M, Anand S, Enas E, Clarke R . Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups. Circulation. 2019; 139(12):1472-1482. DOI: 10.1161/CIRCULATIONAHA.118.034311. View

Bays H, Taub P, Epstein E, Michos E, Ferraro R, Bailey A . Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol. 2021; 5:100149. PMC: 8315386. DOI: 10.1016/j.ajpc.2021.100149. View

Misra A, Chowbey P, Makkar B, Vikram N, Wasir J, Chadha D . Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009; 57:163-70. View

Zhang R, Manohar N, Arsoniadis E, Wang Y, Adam T, Pakhomov S . Evaluating Term Coverage of Herbal and Dietary Supplements in Electronic Health Records. AMIA Annu Symp Proc. 2016; 2015:1361-70. PMC: 4765597. View

10.

Deurenberg P, Deurenberg-Yap M, Guricci S . Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev. 2002; 3(3):141-6. DOI: 10.1046/j.1467-789x.2002.00065.x. View

11.

Asher G, Corbett A, Hawke R . Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017; 96(2):101-107. View

12.

Naito R, Miyauchi K, Daida H . Racial Differences in the Cholesterol-Lowering Effect of Statin. J Atheroscler Thromb. 2016; 24(1):19-25. PMC: 5225129. DOI: 10.5551/jat.RV16004. View

13.

Ma R, Chan J . Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013; 1281:64-91. PMC: 3708105. DOI: 10.1111/nyas.12098. View

14.

Fitch A, Bays H . Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2023; 1:100004. PMC: 10661988. DOI: 10.1016/j.obpill.2021.100004. View

15.

Pan X, Wang L, Pan A . Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(6):373-392. DOI: 10.1016/S2213-8587(21)00045-0. View

16.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

17.

Sun X, Liu Z, Du T . Secular trends in the prevalence of abdominal obesity among Chinese adults with normal weight, 1993-2015. Sci Rep. 2021; 11(1):16404. PMC: 8360975. DOI: 10.1038/s41598-021-95777-y. View

18.

Lo C, Nguyen S, Yang C, Witt L, Wen A, Vivian Liao T . Pharmacogenomics in Asian Subpopulations and Impacts on Commonly Prescribed Medications. Clin Transl Sci. 2020; 13(5):861-870. PMC: 7485947. DOI: 10.1111/cts.12771. View

19.

Wu H, Hristeva N, Chang J, Liang X, Li R, Frassetto L . Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions. J Pharm Sci. 2017; 106(9):2751-2757. PMC: 5675025. DOI: 10.1016/j.xphs.2017.03.027. View

20.

Volgman A, Palaniappan L, Aggarwal N, Gupta M, Khandelwal A, Krishnan A . Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association. Circulation. 2018; 138(1):e1-e34. DOI: 10.1161/CIR.0000000000000580. View